Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Haris Zahoor"'
Autor:
Bino Varghese, Steven Cen, Haris Zahoor, Imran Siddiqui, Manju Aron, Akash Sali, Suhn Rhie, Xiaomeng Lei, Marielena Rivas, Derek Liu, Darryl Hwang, David Quinn, Mihir Desai, Ulka Vaishampayan, Inderbir Gill, Vinay Duddalwar
Publikováno v:
European Journal of Radiology Open, Vol 9, Iss , Pp 100440- (2022)
Objectives: To identify computed tomography (CT)-based radiomic signatures of cluster of differentiation 8 (CD8)-T cell infiltration and programmed cell death ligand 1 (PD-L1) expression levels in patients with clear-cell renal cell carcinoma (ccRCC)
Externí odkaz:
https://doaj.org/article/90dae9be3c1247ed895c958fbfc62127
Autor:
Haris Zahoor, Pedro C. Barata, Xuefei Jia, Allison Martin, Kimberly D. Allman, Laura S. Wood, Timothy D. Gilligan, Petros Grivas, Moshe C. Ornstein, Jorge A. Garcia, Brian I. Rini
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-8 (2018)
Abstract Background Nivolumab is approved for the treatment of refractory metastatic renal cell carcinoma. Patterns and predictors of progressive disease (PD) on nivolumab, and outcomes in such patients are lacking. Methods A retrospective analysis o
Externí odkaz:
https://doaj.org/article/f6ec2bd029234b5785f346286c3599fb
Autor:
Duraisamy Kempuraj, Ramasamy Thangavel, Govindhasamy P. Selvakumar, Smita Zaheer, Mohammad E. Ahmed, Sudhanshu P. Raikwar, Haris Zahoor, Daniyal Saeed, Prashant A. Natteru, Shankar Iyer, Asgar Zaheer
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 11 (2017)
Neuroinflammatory response is primarily a protective mechanism in the brain. However, excessive and chronic inflammatory responses can lead to deleterious effects involving immune cells, brain cells and signaling molecules. Neuroinflammation induces
Externí odkaz:
https://doaj.org/article/867524e3c7d14fab89a08e2f951b7e90
Autor:
Ahmad A Tarhini, Yan Lin, Haris Zahoor, Yongli Shuai, Lisa H Butterfield, Steven Ringquist, Helen Gogas, Cindy Sander, Sandra Lee, Sanjiv S Agarwala, John M Kirwood
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132745 (2015)
E1697 was a phase III trial of adjuvant interferon (IFN)-α2b for one month (Arm B) versus observation (Arm A) in patients with resected melanoma at intermediate risk. We evaluated the levels of candidate serum cytokines, the HLA genotype, polymorphi
Externí odkaz:
https://doaj.org/article/3a8d1bd466564c68aaa1176e7fb1bae5
Autor:
Derek Liu, Komal Dani, Sharath S Reddy, Xiaomeng Lei, Natalie Demirjian, Darryl Hwang, Bino A Varghese, Suhn Kyong Rhie, Felix Y. Yap, David I. Quinn, Imran Siddiqi, Manju Aron, Ulka Vaishampayan, Haris Zahoor, Steven Y Cen, Inderbir S Gill, Vinay Duddalwar
Publikováno v:
Oncology.
OBJECTIVES: This study investigates how quantitative texture analysis can be used to non-invasively identify novel radiogenomic correlations with Clear Cell Renal Cell Carcinoma (ccRCC) biomarkers. METHODS: The Cancer Genome Atlas–Kidney Renal Clea
Autor:
Marielena Rivas, Xiaomeng Lei, Manju Aron, Steven Cen, Imran Siddiqui, Vinay Duddalwar, Suhn K. Rhie, Derek Liu, Felix Y. Yap, Inderbir S. Gill, Darryl Hwang, Natalie L. Demirjian, Brandon K. K. Fields, Haris Zahoor, Bino Varghese, Mihir M. Desai, Sharath S. Reddy
Publikováno v:
European Radiology. 32:2552-2563
To evaluate the utility of CT-based radiomics signatures in discriminating low-grade (grades 1–2) clear cell renal cell carcinomas (ccRCC) from high-grade (grades 3–4) and low TNM stage (stages I–II) ccRCC from high TNM stage (stages III–IV).
Publikováno v:
Kidney Cancer. 3:93-102
The treatment landscape of advanced renal cell carcinoma (RCC) is rapidly evolving. Immune checkpoint inhibitors (ICI) have now become the preferred first line treatment with the approval of nivolumab and ipilimumab combination in intermediate to poo
Autor:
Robert Dreicer, Haris Zahoor, Andrew J. Stephenson, Jorge A. Garcia, Steven C. Campbell, Amr Fergany, Maria Carmen Mir, Pedro C. Barata
Publikováno v:
Investigational New Drugs. 37:1231-1238
Purpose Sunitinib is a vascular endothelial growth factor receptor (VEGFR) inhibitor with antitumor activity against bladder cancer. We hypothesized that treatment with sunitinib may decrease progression or recurrence in non-muscle invasive bladder c
Autor:
Haris Zahoor, Daniyal Saeed, Govindhasamy Pushpavathi Selvakumar, Smita Zaheer, Ramasamy Thangavel, Shankar S. Iyer, Duraisamy Kempuraj, Iuliia Dubova, Shireen Mentor, Mohammad Ejaz Ahmed, Sudhanshu P. Raikwar, Arshdeep S Dhaliwal, Keerthivaas Premkumar, Asgar Zaheer
Publikováno v:
Neuroscientist
Traumatic brain injury (TBI) is a major health problem in the United States, which affects about 1.7 million people each year. Glial cells, T-cells, and mast cells perform specific protective functions in different regions of the brain for the recove
Autor:
Shireen Mentor, Daniyal Saeed, Smita Zaheer, Sudhanshu P. Raikwar, Mohammad Ejaz Ahmed, Haris Zahoor, Shankar S. Iyer, Govindhasamy Pushpavathi Selvakumar, Keerthivaas Premkumar, Asgar Zaheer, Iuliia Dubova, Ramasamy Thangavel, Duraisamy Kempuraj, Ragha Chaitanya Sakuru, Nidhi Shankar Kikkeri
Publikováno v:
J Neuroimmune Pharmacol
Despite significant advancements in the field of molecular neurobiology especially neuroinflammation and neurodegeneration, the highly complex molecular mechanisms underlying neurodegenerative diseases remain elusive. As a result, the development of